PDGFRB and Hepatic fibrosis: The sensitivity, specificity, PPV, and NPV of PDGFRβ to predict significant liver fibrosis (≥ F2) in diabetic MAFLD patients were 85%, 93.33%, 89.5%, and 90.3%, respectively, at a cutoff level > 2.54 (AUC = 0.905, CI = 0.810–1.0, P < 0.001).